MRUS vs. NVO

Last updated Apr 2, 2026

Compare and contrast key facts about Merus N.V. (MRUS) and Novo Nordisk A/S (NVO).

Performance

MRUS vs. NVO - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in Merus N.V. (MRUS) and Novo Nordisk A/S (NVO). The values are adjusted to include any dividend payments, if applicable.

MRUS vs. NVO - Yearly Performance Comparison

	2026 (YTD)	2025	2024	2023	2022	2021	2020	2019	2018	2017
MRUS Merus N.V.	0.00%	114.03%	52.91%	77.76%	-51.35%	81.40%	24.50%	0.57%	-27.84%	-8.10%
NVO Novo Nordisk A/S	-25.80%	-39.22%	-15.93%	54.84%	22.66%	63.52%	23.33%	28.70%	-12.98%	52.92%

Fundamentals

Market Cap MRUS : $6.81B NVO : $162.26B
EPS MRUS : -$4.56 NVO : $22.15
PS Ratio MRUS : 129.06 NVO : 0.55
PB Ratio MRUS : 10.29 NVO : 0.84
Total Revenue (TTM) MRUS : $51.17M NVO : $297.20B
Gross Profit (TTM) MRUS : -$111.30M NVO : $240.66B
EBITDA (TTM) MRUS : -$323.66M NVO : $153.18B

Returns By Period

MRUS

• 1D: —
• 1M: —
• YTD: —
• 6M: —
• 1Y: —
• 3Y*: —
• 5Y*: —
• 10Y*: —

NVO

• 1D: -0.73%
• 1M: -0.01%
• YTD: -25.80%
• 6M: -36.19%
• 1Y: -43.88%
• 3Y*: -20.88%
• 5Y*: 3.69%
• 10Y*: 5.04%

*Multi-year figures are annualized to reflect compound growth (CAGR)

Return for Risk

MRUS vs. NVO — Risk / Return Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.

NVO

NVO Risk / Return Rank: 10
NVO Sharpe Ratio Rank: 8
NVO Sortino Ratio Rank: 11
NVO Omega Ratio Rank: 10
NVO Calmar Ratio Rank: 11
NVO Martin Ratio Rank: 11

The rank (0–100) shows how this investment's returns compare to the risk taken. Higher = better. Based on the past 12 months of data, combining Sharpe, Sortino, and other metrics used by quantitative funds and institutional investors.

MRUS vs. NVO - Risk-Adjusted Trends Comparison

This table presents a comparison of risk-adjusted performance metrics for Merus N.V. (MRUS) and Novo Nordisk A/S (NVO). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.

Risk / return metrics aren't available yet — we need at least 12 months of trading data to calculate them.

Sharpe Ratios by Period

	MRUS	NVO	Difference
Sharpe Ratio (1Y) Calculated over the trailing 1-year period	—	-0.81	—
Sharpe Ratio (5Y) Calculated over the trailing 5-year period	—	0.10	—
Sharpe Ratio (10Y) Calculated over the trailing 10-year period	—	0.16	—
Sharpe Ratio (All Time) Calculated using the full available price history	—	0.46	—

Correlation

The correlation between MRUS and NVO is 0.14, which is considered to be low. This implies their price changes are not closely related. A low correlation is generally favorable for portfolio diversification, as it helps to reduce overall risk by spreading it across multiple assets with different performance patterns.

Dividends

MRUS vs. NVO - Dividend Comparison

MRUS has not paid dividends to shareholders, while NVO's dividend yield for the trailing twelve months is around 4.94%.

	TTM	2025	2024	2023	2022	2021	2020	2019	2018	2017	2016	2015
MRUS Merus N.V.	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
NVO Novo Nordisk A/S	4.94%	3.31%	1.68%	1.00%	1.20%	1.35%	1.87%	2.14%	1.45%	1.52%	2.87%	0.92%

Drawdowns

Drawdown Indicators

	MRUS	NVO	Difference
Max Drawdown Largest peak-to-trough decline	—	-74.70%	—
Max Drawdown (1Y) Largest decline over 1 year	—	-55.03%	—
Max Drawdown (5Y) Largest decline over 5 years	—	-74.70%	—
Max Drawdown (10Y) Largest decline over 10 years	—	-74.70%	—
Current Drawdown Current decline from peak	—	-73.49%	—
Average Drawdown Average peak-to-trough decline	—	-17.56%	—
Ulcer Index Depth and duration of drawdowns from previous peaks	—	31.83%	—

Volatility

Volatility by Period

	MRUS	NVO	Difference
Volatility (1M) Calculated over the trailing 1-month period	—	9.39%	—
Volatility (6M) Calculated over the trailing 6-month period	—	38.79%	—
Volatility (1Y) Calculated over the trailing 1-year period	—	54.16%	—
Volatility (5Y) Calculated over the trailing 5-year period, annualized	—	37.82%	—
Volatility (10Y) Calculated over the trailing 10-year period, annualized	—	32.28%	—

Financials